GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Medicilon Inc (SHSE:688202) » Definitions » Scaled Net Operating Assets

Shanghai Medicilon (SHSE:688202) Scaled Net Operating Assets : 0.67 (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Medicilon Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shanghai Medicilon's operating assets for the quarter that ended in Sep. 2024 was ¥2,293.3 Mil. Shanghai Medicilon's operating liabilities for the quarter that ended in Sep. 2024 was ¥310.1 Mil. Shanghai Medicilon's Total Assets for the quarter that ended in Jun. 2024 was ¥2,962.2 Mil. Therefore, Shanghai Medicilon's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.67.


Shanghai Medicilon Scaled Net Operating Assets Historical Data

The historical data trend for Shanghai Medicilon's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Medicilon Scaled Net Operating Assets Chart

Shanghai Medicilon Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.64 0.61 0.94 0.82

Shanghai Medicilon Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.54 0.61 0.64 0.67

Competitive Comparison of Shanghai Medicilon's Scaled Net Operating Assets

For the Biotechnology subindustry, Shanghai Medicilon's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Medicilon's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Medicilon's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Shanghai Medicilon's Scaled Net Operating Assets falls into.


;
;

Shanghai Medicilon Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shanghai Medicilon's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(2275.745-372.19)/2329.581
=0.82

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3265.847 - 990.102
=2275.745

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=755.068 - 14.28 - 368.598
=372.19

Shanghai Medicilon's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(2293.295-310.094)/2962.186
=0.67

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2948.181 - 654.886
=2293.295

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=596.326 - 11.187 - 275.045
=310.094

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Medicilon Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Shanghai Medicilon's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Medicilon Business Description

Traded in Other Exchanges
N/A
Address
Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299
Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.
Executives
Chen Jin Zhang Director
Chen Guo Xing Director
Lin Zhang Qing Director
Peng Shuang Qing Core technical personnel
Li Zhi Gang Core technical personnel
Xu Yong Mei Core technical personnel
Liu Bin Bin senior management
Zhang Xiao Dong senior management
Xue Chao senior management
Ma Xing Quan senior management
Directors, senior managers, core technical personn
Cai Jin Na Directors, senior managers

Shanghai Medicilon Headlines

No Headlines